drugset
drugset / Trial / NCT06817187

Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine

NCT06817187 ↗

Phase 3 Completed 1110 enrolled Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
RandomizedSequentialOpen-labelPrevention

Summary

This clinical study aims to evaluate the mutual influence of combined administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis Vaccine in the target population

Timeline

Start
2021-09-16
Primary completion
2024-03-13
Completion
2024-03-13

Drugs

EvaluationDrugModalityDoseRoute
Subject 15-Valent Pneumococcal Conjugate Vaccine Vaccine 0.5 ml —
Subject Diphtheria, Tetanus and Acellular pertussis (Component) Combined Vaccine (Adsorbed) Vaccine 0.5 ml —

Indications

pneumococcal infection